Type C Lymphomatoid Papulosis Following Immune Checkpoint Inhibition in a Melanoma Patient: A Reactive Mimicker of Cutaneous CD30⁺ Lymphoma
Keywords:
Lymphomatoid papulosis, Immune checkpoint inhibitors, DermoscopyAbstract
Letter to the Editor
References
Fricke T, Kempf W, Schön MP, et al. Histologic and Immunohistochemical Patterns in Lymphomatoid Papulosis: A Systematic Review of Published Cases. Dermatopathology. 2025;12(1):6. DOI:10.3390/dermatopathology12010006
Geisler AN, Phillips GS, Barrios DM, et al. Immune checkpoint inhibitor-related dermatologic adverse events. J Am Acad Dermatol. 2020;83(5):1255-1268. DOI:10.1016/j.jaad.2020.03.132
Seçkin D, Barete S, Euvrard S, et al. Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series. Am J Transplant. 2013;13(8):2146-2153. DOI:10.1111/ajt.12281
Ferranti M, Tadiotto Cicogna G, Russo I, et al. Immunomodulation in Cutaneous T Cell Lymphoma. Front Oncol. 2019;9:1025. DOI:10.3389/fonc.2019.01025
Ungureanu L, Vasilovici A, Șenilă SC, et al. Dermoscopy in the diagnosis of cutaneous lymphoma (Review). Exp Ther Med. 2022;23(6):377. DOI:10.3892/etm.2022.11304
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alex Moscardi, Jacopo Tartaglia, Christian Ciolfi, Mauro Alaibac

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

